EPO-BUL-01 - Study of the Optimization of Anemia Management of EPREX (Epoetin Alfa) in Predialysis Patients With Chronic Renal Failure
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00338000 |
|
Recruitment Status
:
Completed
First Posted
: June 20, 2006
Last Update Posted
: February 1, 2011
|
Sponsor:
Janssen Pharmaceutica N.V., Belgium
Information provided by:
Janssen Pharmaceutica N.V., Belgium
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Primary Completion Date : | No date given |
| Actual Study Completion Date : | May 2005 |